GL1X · GenesisL1 explorer

MolNFT v1 · #27405 · protein

Crystal structure of the agonist-bound ligand-binding domain of biomphalaria glabrata rxr

1XIU · Rxr-like protein: “Crystal structure of the agonist-bound ligand-binding domain of biomphalaria glabrata rxr”. X-ray diffraction, 1 ligand (9CR), 6 pockets (best druggability 0.83). MolNFT v1 #27405 on GenesisL1: 3D structure…

PDB
1XIU
Type
protein
Length
467 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Rxr-like protein; Nuclear receptor coactivator 1
EC
2.3.1.48
UniProt
Q15788
Ligands
9CR
Pockets
6 · best druggability 0.83

Structure

x-ray diffraction · 4 distinct chains · 69% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARxr-like proteinprotein22169% helix, 5% strand—
BRxr-like proteinprotein22468% helix, 4% strand—
ENuclear receptor coactivator 1 (EC 2.3.1.48)protein1275% helix, 0% strandQ15788
FNuclear receptor coactivator 1 (EC 2.3.1.48)protein1060% helix, 0% strandQ15788

Ligands and binding sites

  • 9CR · (9cis)-retinoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13050.830.93479CR
23370.800.90469CR
35130.670.7846empty
4650.540.8711empty
51400.500.7813empty

Interfaces

3 interfaces between chains.

  • A–B · 1126 Ų buried · 11 hydrogen bonds · protein-protein
  • B–F · 490 Ų buried · 6 hydrogen bonds · protein-protein
  • A–E · 475 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 1XIU · Crystal structure of the agonist-bound ligand-binding domain of Biomphalaria glabrata RXR · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.